N‑acetyl‑L‑cysteine reduces arsenite‑induced cytotoxicity through chelation in U937 monocytes and macrophages

Ghani,Sidra; Khan,Noureen; Koriyama,Chihaya; Akiba,Suminori; Yamamoto,Megumi

doi:10.3892/mmr.2014.2612

N‑acetyl‑L‑cysteine reduces arsenite‑induced cytotoxicity through chelation in U937 monocytes and macrophages

Authors:
- Sidra Ghani
- Noureen Khan
- Chihaya Koriyama
- Suminori Akiba
- Megumi Yamamoto
View Affiliations

Affiliations: Department of Epidemiology and Preventive Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima 890‑8544, Japan, Integrated Physiology Section, Department of Basic Medical Science, National Institute for Minamata Disease, Minamata, Kumamoto 867‑0008, Japan
Published online on: October 8, 2014 https://doi.org/10.3892/mmr.2014.2612
Pages: 2961-2966

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the present study, in order to clarify the preventive mechanism of N‑acetyl‑L‑cysteine (NAC) on arsenite‑induced apoptosis in U937 cells, which lack functional p53, the cytotoxicity among U937 cells [monocytes and 12‑O‑tetradecanoylphorbol‑13‑acetate (TPA)‑treated macrophages] receiving NAC treatment at different times post arsenite treatment was examined. TPA‑treated macrophages were more resistant to arsenite‑induced apoptosis than monocytes, which may be associated with the induction of Bcl‑2 expression. Pretreatment with 20 mM NAC prior to arsenite exposure suppressed apoptosis up to 75% in the monocytes and 100% in the macrophages. However, 6‑h NAC pretreatment and subsequent washing out of NAC from the culture medium prior to arsenite treatment did not inhibit the arsenite‑induced apoptosis. Post‑treatment by NAC up to 1 h following arsenite exposure almost completely inhibited the cytotoxic effects of arsenite in U937 monocytes and macrophages. The results of the current study indicate that the preventive mechanism of NAC on arsenite‑induced apoptosis in U937 monocytes and macrophages mainly involves chelation of arsenite in culture medium.

View Figures

View References

1	States JC, Barchowsky A, Cartwright IL, Reichard JF, Futscher BW and Lantz RC: Arsenic toxicology: translating between experimental models and human pathology. Environ Health Perspect. 119:1356–1363. 2011. View Article : Google Scholar
2	Nickson RT, McArthur JM, Shrestha B, Kyaw-Myint TO and Lowry D: Arsenic and other drinking water quality issues, Muzaffargarh District, Pakistan. Appl Geochem. 20:55–68. 2005. View Article : Google Scholar
3	Uqaili AA, Mughal AH and Maheshwari BK: Arsenic contamination in ground water sources of district Matiari, Sindh. Int J Eng Res Appl. 3:259–266. 2012.
4	Ahmad SA, Gulzar A, Rehman HU, Soomro ZA, Hussain M, Rehman MU and Qadir MA: Study of arsenic in drinking water of distric Kasur Pakistan. World Appl Sci J. 24:634–640. 2013.
5	Ashraf M, Tariq J and Jaffar M: Contents of trace metals in fish, sediment and water from three freshwater reservoirs on the Indus River, Pakistan. Fish Res. 12:355–364. 1991. View Article : Google Scholar
6	Marchiset-Ferlay N, Savanovitch C and Sauvant-Rochat MP: What is the best biomarker to assess arsenic exposure via drinking water? Environ Int. 39:150–171. 2012. View Article : Google Scholar : PubMed/NCBI
7	Smith AH, Goycolea M, Haque R and Biggs ML: Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol. 147:660–669. 1998. View Article : Google Scholar : PubMed/NCBI
8	Biswas R, Ghosh P, Banerjee N, Das JK, Sau T, Banerjee A, Roy S, Ganguly S, Chatterjee M, Mukherjee A and Giri AK: Analysis of T-cell proliferation and cytokine secretion in the individuals exposed to arsenic. Hum Exp Toxicol. 27:381–386. 2008. View Article : Google Scholar : PubMed/NCBI
9	Banerjee N, Banerjee M, Ganguly S, Bandyopadhyay S, Das JK, Bandyopadhay A, Chatterjee M and Giri AK: Arsenic-induced mitochondrial instability leading to programmed cell death in the exposed individuals. Toxicology. 246:101–111. 2008. View Article : Google Scholar : PubMed/NCBI
10	Banerjee N, Banerjee S, Sen R, Bandyopadhyay A, Sarma N, Majumder P, Das JK, Chatterjee M, Kabir SN and Giri AK: Chronic arsenic exposure impairs macrophage functions in the exposed individuals. J Clin Immunol. 29:582–594. 2009. View Article : Google Scholar : PubMed/NCBI
11	Luna AL, Acosta-Saavedra LC, Lopez-Carrillo L, Conde P, Vera E, De Vizcaya-Ruiz A, Bastida M, Cebrian ME and Calderon-Aranda ES: Arsenic alters monocyte superoxide anion and nitric oxide production in environmentally exposed children. Toxicol Appl Pharmacol. 245:244–251. 2010. View Article : Google Scholar : PubMed/NCBI
12	Ramos AM, Fernández C, Amrán D, Sancho P, de Blas E and Aller P: Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells. Blood. 105:4013–4020. 2005. View Article : Google Scholar
13	Foti A, Bar-Eli M, Ahuja HG and Cline MJ: A splicing mutation accounts for the lack of p53 gene expression in a CML blast crisis cell line: a novel mechanism of p53 gene inactivation. Br J Haematol. 76:143–145. 1990. View Article : Google Scholar : PubMed/NCBI
14	Vogel CF, Sciullo E, Wong P, Kuzmicky P, Kado N and Matsumura F: Induction of proinflammatory cytokines and C-reactive protein in human macrophage cell line U937 exposed to air pollution particulates. Environ Health Perspect. 113:1536–1541. 2005. View Article : Google Scholar : PubMed/NCBI
15	Yamamoto M, Hirano S, Vogel CF, Cui X and Matsumura F: Selective activation of NF-kappaB and E2F by low concentration of arsenite in U937 human monocytic leukemia cells. J Biochem Mol Toxicol. 22:136–146. 2008. View Article : Google Scholar : PubMed/NCBI
16	Solary E, Bertrand R, Kohn KW and Pommier Y: Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood. 81:1359–1368. 1993.PubMed/NCBI
17	Sordet O, Bettaieb A, Bruey JM, Eymin B, Droin N, Ivarsson M, Garrido C and Solary E: Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells. Cell Death Differ. 6:351–361. 1999. View Article : Google Scholar : PubMed/NCBI
18	Sordet O, Rébé C, Leroy I, Bruey JM, Garrido C, Miguet C, Lizard G, Plenchette S, Corcos L and Solary E: Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis. Blood. 97:3931–3940. 2001. View Article : Google Scholar
19	Iwama K, Nakajo S, Aiuchi T and Nakaya K: Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca²⁺-dependent production of superoxide. Int J Cancer. 92:518–526. 2001. View Article : Google Scholar : PubMed/NCBI
20	Fernández C, Ramos AM, Sancho P, Amrán D, de Blas E and Aller P: 12-O-tetradecanoylphorbol-13-acetate may both potentiate and decrease the generation of apoptosis by the antileukemic agent arsenic trioxide in human promonocytic cells. Regulation by extracellular signal-regulated protein kinases and glutathione. J Biol Chem. 279:3877–3884. 2004.
21	Flora SJ: Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med. 51:257–281. 2011. View Article : Google Scholar : PubMed/NCBI
22	Henderson P, Hale TW, Shum S and Habersang RW: N-Acetylcysteine therapy of acute heavy metal poisoning in mice. Vet Hum Toxicol. 27:522–525. 1985.PubMed/NCBI
23	Reddy PS, Rani GP, Sainath SB, Meena R and Supriya Ch: Protective effects of N-acetylcysteine against arsenic-induced oxidative stress and reprotoxicity in male mice. J Trace Elem Med Biol. 25:247–253. 2011. View Article : Google Scholar : PubMed/NCBI
24	Banner W Jr, Koch M, Capin DM, Hopf SB, Chang S and Tong TG: Experimental chelation therapy in chromium, lead, and boron intoxication with N-acetylcysteine and other compounds. Toxicol Appl Pharmacol. 83:142–147. 1986. View Article : Google Scholar : PubMed/NCBI
25	Ho SY, Wu WJ, Chiu HW, Chen YA, Ho YS, Guo HR and Wang YJ: Arsenic trioxide and radiation enhance apoptotic effects in HL-60 cells through increased ROS generation and regulation of JNK and p38 MAPK signaling pathways. Chem Biol Interact. 193:162–171. 2011. View Article : Google Scholar : PubMed/NCBI
26	Liu YQ, You S, Zhang CL, Tashiro S, Onodera S and Ikejima T: Oridonin enhances phagocytosis of UV-irradiated apoptotic U937 cells. Biol Pharm Bull. 28:461–467. 2005. View Article : Google Scholar : PubMed/NCBI
27	Hirano S, Cui X, Li S, Kanno S, Kobayashi Y, Hayakawa T and Shraim A: Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells. Arch Toxicol. 77:305–312. 2003.
28	Riganti C, Aldieri E, Bergandi L, Tomatis M, Fenoglio I, Costamagna C, Fubini B, Bosia A and Ghigo D: Long and short fiber amosite asbestos alters at a different extent the redox metabolism in human lung epithelial cells. Toxicol Appl Pharmacol. 193:106–115. 2003. View Article : Google Scholar
29	Hirano S, Kobayashi Y, Cui X, Kanno S, Hayakawa T and Shraim A: The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds. Toxicol Appl Pharmacol. 198:458–467. 2004. View Article : Google Scholar : PubMed/NCBI
30	Rosato RR, Almenara JA and Grant S: The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. Cancer Res. 63:3637–3645. 2003.
31	Martin DS, Willis SE and Cline DM: N-acetylcysteine in the treatment of human arsenic poisoning. J Am Board Fam Pract. 3:293–296. 1990.PubMed/NCBI
32	United States Environmental Protection Agency. Proven alternatives for aboveground treatment of arsenic in groundwater. EPA-542-S-02-002. EPA; New York, NY, USA: 2002
33	Shiiki K, Yoshikawa H, Kinoshita H, Takeda M, Ueno A, Nakajima Y and Tasaka K: Potential mechanisms of resistance to TRAIL/Apo2L-induced apoptosis in human promyelocytic leukemia HL-60 cells during granulocytic differentiation. Cell Death Differ. 7:939–946. 2000. View Article : Google Scholar
34	Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
35	Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1132–1136. 1997. View Article : Google Scholar : PubMed/NCBI
36	Meinhardt G, Roth J and Hass R: Activation of protein kinase C relays distinct signaling pathways in the same cell type: differentiation and caspase-mediated apoptosis. Cell Death Differ. 7:795–803. 2000. View Article : Google Scholar
37	Meinhardt G, Roth J and Totok G: Protein kinase C activation modulates pro- and anti-apoptotic signaling pathways. Eur J Cell Biol. 79:824–833. 2000. View Article : Google Scholar : PubMed/NCBI
38	Takada Y, Hachiya M, Osawa Y, Hasegawa Y, Ando K, Kobayashi Y and Akashi M: 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis is mediated by tumor necrosis factor alpha in human monocytic U937 cells. J Biol Chem. 274:28286–28292. 1999. View Article : Google Scholar : PubMed/NCBI